These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 36350094)
1. How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT). Li B; Sangkuhl K; Keat K; Whaley RM; Woon M; Verma S; Dudek S; Tuteja S; Verma A; Whirl-Carrillo M; Ritchie MD; Klein TE Clin Pharmacol Ther; 2023 May; 113(5):1036-1047. PubMed ID: 36350094 [TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics Clinical Annotation Tool (PharmCAT). Sangkuhl K; Whirl-Carrillo M; Whaley RM; Woon M; Lavertu A; Altman RB; Carter L; Verma A; Ritchie MD; Klein TE Clin Pharmacol Ther; 2020 Jan; 107(1):203-210. PubMed ID: 31306493 [TBL] [Abstract][Full Text] [Related]
3. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population. Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877 [TBL] [Abstract][Full Text] [Related]
4. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank. Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824 [TBL] [Abstract][Full Text] [Related]
5. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data. Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851 [TBL] [Abstract][Full Text] [Related]
6. DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium. Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; Turner AJ; van Schaik RHN; Whirl-Carrillo M; Weck KE J Mol Diagn; 2024 Oct; 26(10):851-863. PubMed ID: 39032821 [TBL] [Abstract][Full Text] [Related]
7. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice. Cecchin E; Roncato R; Guchelaar HJ; Toffoli G; Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932 [TBL] [Abstract][Full Text] [Related]
9. Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy. Pratt VM; Cavallari LH; Del Tredici AL; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE J Mol Diagn; 2021 Sep; 23(9):1047-1064. PubMed ID: 34118403 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics Guidelines: Overview and Comparison of the DPWG, CPIC, CPNDS, and RNPGx Guidelines. Abdullah-Koolmees H; van Keulen AM; Nijenhuis M; Deneer VHM Front Pharmacol; 2020; 11():595219. PubMed ID: 33568995 [TBL] [Abstract][Full Text] [Related]
11. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade. Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514 [TBL] [Abstract][Full Text] [Related]
12. Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group. Caudle KE; Sangkuhl K; Whirl-Carrillo M; Swen JJ; Haidar CE; Klein TE; Gammal RS; Relling MV; Scott SA; Hertz DL; Guchelaar HJ; Gaedigk A Clin Transl Sci; 2020 Jan; 13(1):116-124. PubMed ID: 31647186 [TBL] [Abstract][Full Text] [Related]
14. CYP3A4 and CYP3A5 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase. Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE J Mol Diagn; 2023 Sep; 25(9):619-629. PubMed ID: 37419245 [TBL] [Abstract][Full Text] [Related]
15. TPMT and NUDT15 Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, and Pharmacogenomics Knowledgebase. Pratt VM; Cavallari LH; Fulmer ML; Gaedigk A; Hachad H; Ji Y; Kalman LV; Ly RC; Moyer AM; Scott SA; van Schaik RHN; Whirl-Carrillo M; Weck KE J Mol Diagn; 2022 Oct; 24(10):1051-1063. PubMed ID: 35931343 [TBL] [Abstract][Full Text] [Related]
16. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines. Pritchard D; Patel JN; Stephens LE; McLeod HL Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418 [TBL] [Abstract][Full Text] [Related]
17. Using the PharmCAT tool for Pharmacogenetic clinical decision support. Tippenhauer K; Philips M; Largiadèr C; Sariyar M Brief Bioinform; 2023 Nov; 25(1):. PubMed ID: 38055839 [TBL] [Abstract][Full Text] [Related]
18. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing. van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729 [TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis. Lenz C; Narang A; Bousman CA Pharmacogenet Genomics; 2024 Jun; 34(4):130-134. PubMed ID: 38359167 [TBL] [Abstract][Full Text] [Related]
20. Pharmacogenomics decision support in the U-PGx project: Results and advice from clinical implementation across seven European countries. Blagec K; Swen JJ; Koopmann R; Cheung KC; Crommentuijn-van Rhenen M; Holsappel I; Konta L; Ott S; Steinberger D; Xu H; Cecchin E; Dolžan V; Dávila-Fajardo CL; Patrinos GP; Sunder-Plassmann G; Turner RM; Pirmohamed M; Guchelaar HJ; Samwald M; PLoS One; 2022; 17(6):e0268534. PubMed ID: 35675343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]